EP3297617A4 - HOMOGENEOUS CANNABIS COMPOSITIONS AND METHODS OF PRODUCING THE SAME - Google Patents

HOMOGENEOUS CANNABIS COMPOSITIONS AND METHODS OF PRODUCING THE SAME Download PDF

Info

Publication number
EP3297617A4
EP3297617A4 EP16796872.6A EP16796872A EP3297617A4 EP 3297617 A4 EP3297617 A4 EP 3297617A4 EP 16796872 A EP16796872 A EP 16796872A EP 3297617 A4 EP3297617 A4 EP 3297617A4
Authority
EP
European Patent Office
Prior art keywords
homogeneous
producing
methods
same
cannabis compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16796872.6A
Other languages
German (de)
French (fr)
Other versions
EP3297617A1 (en
Inventor
Jeremy H. GOLDSTEIN
Justin Eric SINGER
Adrian VERWOLF
Garret Nicodemus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
5071 Inc
Original Assignee
5071 Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 5071 Inc filed Critical 5071 Inc
Priority claimed from PCT/US2016/025044 external-priority patent/WO2016186735A1/en
Publication of EP3297617A1 publication Critical patent/EP3297617A1/en
Publication of EP3297617A4 publication Critical patent/EP3297617A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/06—Treating tea before extraction; Preparations produced thereby
    • A23F3/14—Tea preparations, e.g. using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP16796872.6A 2015-05-18 2016-03-30 HOMOGENEOUS CANNABIS COMPOSITIONS AND METHODS OF PRODUCING THE SAME Pending EP3297617A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562163316P 2015-05-18 2015-05-18
PCT/US2016/025044 WO2016186735A1 (en) 2015-05-18 2016-03-30 Homogenous cannabis compositions and methods of making the same

Publications (2)

Publication Number Publication Date
EP3297617A1 EP3297617A1 (en) 2018-03-28
EP3297617A4 true EP3297617A4 (en) 2019-02-20

Family

ID=61223555

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16796872.6A Pending EP3297617A4 (en) 2015-05-18 2016-03-30 HOMOGENEOUS CANNABIS COMPOSITIONS AND METHODS OF PRODUCING THE SAME

Country Status (1)

Country Link
EP (1) EP3297617A4 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136752A1 (en) * 2001-02-14 2002-09-26 Gw Pharmaceuticals Limited Pharmaceutical formulations
CN101904401A (en) * 2010-07-09 2010-12-08 云南龙润茶业集团有限公司 Tea jelly sweet
US20110092583A1 (en) * 2005-11-07 2011-04-21 Murty Pharmaceuticals, Inc. Oral Dosage Form Of Tetrahydrocannabinol And A Method Of Avoiding And/Or Suppressing Hepatic First Pass Metabolism Via Targeted Chylomicron/Lipoprotein Delivery
CN103110582A (en) * 2013-03-04 2013-05-22 上海医药工业研究院 Cannabis phenolic compound microemulsion and preparation method thereof
US20150045282A1 (en) * 2008-10-31 2015-02-12 The University Of Mississippi Compositions containing delta-9-thc-amino acid esters and process of preparation
US20150057341A1 (en) * 2013-08-22 2015-02-26 Stephen C. Perry Composition with Pharmacological Effect for Vaporizing and Method
WO2015191728A1 (en) * 2014-06-11 2015-12-17 Poviva Tea, Llc Food and beverage compositions infused with lipophilic active agents and methods of use thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136752A1 (en) * 2001-02-14 2002-09-26 Gw Pharmaceuticals Limited Pharmaceutical formulations
US20110092583A1 (en) * 2005-11-07 2011-04-21 Murty Pharmaceuticals, Inc. Oral Dosage Form Of Tetrahydrocannabinol And A Method Of Avoiding And/Or Suppressing Hepatic First Pass Metabolism Via Targeted Chylomicron/Lipoprotein Delivery
US20150045282A1 (en) * 2008-10-31 2015-02-12 The University Of Mississippi Compositions containing delta-9-thc-amino acid esters and process of preparation
CN101904401A (en) * 2010-07-09 2010-12-08 云南龙润茶业集团有限公司 Tea jelly sweet
CN103110582A (en) * 2013-03-04 2013-05-22 上海医药工业研究院 Cannabis phenolic compound microemulsion and preparation method thereof
US20150057341A1 (en) * 2013-08-22 2015-02-26 Stephen C. Perry Composition with Pharmacological Effect for Vaporizing and Method
WO2015191728A1 (en) * 2014-06-11 2015-12-17 Poviva Tea, Llc Food and beverage compositions infused with lipophilic active agents and methods of use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 201381, Derwent World Patents Index; AN 2013-R00947, XP002787597 *
See also references of WO2016186735A1 *

Also Published As

Publication number Publication date
EP3297617A1 (en) 2018-03-28

Similar Documents

Publication Publication Date Title
EP3286264A4 (en) AEROGELS AND METHODS OF PRODUCING THEM
EP3352577A4 (en) CANNABINOID-BASED COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
PT3317260T (en) COMPOSITIONS OF POTASSIUM ACESSULFAME AND PRODUCTION PROCESSES OF THE SAME
EP3397261A4 (en) METHODS AND COMPOSITIONS RELATING TO THE CHONDRISOMES
EP3458531A4 (en) COATING COMPOSITIONS AND METHODS OF PREPARING THE SAME
EP3408326A4 (en) ELASTOMERIC ARTICLES, COMPOSITIONS, AND METHODS OF PRODUCTION THEREFOR
KR20180084891A (en) Structural compositions and methods
PL3386534T3 (en) Compositions and methods for the internalisation of enzymes
EP3271123A4 (en) MANUFACTURE OF REACTIVE ADDITIVE
MA43380A (en) MODIFIED CHEMERICAL RECEPTORS AND ASSOCIATED COMPOSITIONS AND PROCESSES
PL4279535T3 (en) Methods of producing polyols
IL250744A0 (en) Method of producing palbociclib and pharmaceutical compositions comprising the same
PT3355990T (en) SEMIFLUORED COMPOUNDS AND THEIR COMPOSITIONS
EP3478308A4 (en) CANNABIS COMPOSITIONS AND PROCEDURES
EP3356595A4 (en) METHODS OF PRODUCING NANOCELLULOSE, AND NANOCELLULOSE COMPOSITIONS PRODUCED THEREFROM
EP3273945C0 (en) CONTINUOUS PRODUCTION OF PARTICLES
HUE059158T2 (en) Process for the preparation of pridopidine
EP3289087A4 (en) METHODS AND COMPOSITIONS FOR PRODUCING BACHY CORN PLANTS
EP3503879A4 (en) COMPOSITIONS AND RELATED METHODS
LT3652491T (en) METHOD OF LYOPHILISATION OF THE PRODUCT
MA53939A (en) HEMOSTATIC COMPOSITIONS AND METHODS OF MAKING THEM
PL3142785T3 (en) METHOD OF PREPARATION OF ALKENOLS AND THEIR APPLICATION FOR THE PRODUCTION OF 1,3-BUTADIENE
IL256322B (en) Improved formulations of deprasirox and methods of their manufacture
FI20155385A7 (en) Methods for the continuous production of products from microorganisms
EP3393655A4 (en) FENFLURAMINE COMPOSITIONS AND METHODS OF PREPARATION THEREOF

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20190109BHEP

Ipc: A61K 31/05 20060101ALI20190109BHEP

Ipc: A23L 2/52 20060101ALI20190109BHEP

Ipc: A61K 9/16 20060101AFI20190109BHEP

Ipc: A61K 31/352 20060101ALI20190109BHEP

Ipc: A23F 3/14 20060101ALI20190109BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190118

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230102